One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-124552
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 2 |
Affiliation: Northside Hospital, University of California, Los Angeles, Vanderbilt University, Leukemia & Lymphoma Society of Canada, University of Rochester, University of Kansas, Jazz Pharmaceuticals (United States), Northwell Health, The University of Texas MD Anderson Cancer Center, Cornell University, University of California, San DiegoEfficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (AML) with Prior Hypomethylating Agent Exposure Who Achieved Remission
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
